Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Interleukin 17F (IL-17F) is a pro-inflammatory cytokine belonging to the interleukin 17 family. It is primarily produced by T helper 17 (Th17) cells and plays a central role in host defense against extracellular bacteria and fungi by inducing neutrophil recruitment and activation at sites of infection or inflammation. IL-17F is implicated in the pathogenesis of chronic inflammatory and autoimmune diseases, including asthma, rheumatoid arthritis, psoriasis, and inflammatory bowel disease. It signals through a heterodimeric receptor complex composed of IL-17RA and IL-17RC, activating downstream pathways including NF-kB and MAPK.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Interleukin 17F (IL-17F).